Purpose Inadequacies in several micronutrients in complementary foods, notably iron, zinc, calcium, vitamin A, vitamin B6 and riboflavin have been reported. Moringa oleifera leaf powder (MLP), prepared from dried moringa leaves is nutrient-rich and has been explored for the treatment of micronutrient deficiencies among children in developing countries. This increasing interest in the use of moringa oleifera leaves to improve complementary foods notwithstanding, the unique sensory characteristics of the leaf powder potentially holds implications for the acceptability of local diets that are fortified with it. The purpose of this paper is to investigate the levels of MLP fortification that are most acceptable for feeding infants and young children. Design/methodology/approach The authors performed a review of the literature, with the aim of investigating the sensory attributes and acceptable levels of fortification of complementary food blends fortified with different levels of MLP. Findings The minimum amount of MLP to be added to a complementary food blend to observe significant improvements in its nutritional value was estimated to be about 10 per cent. However, at this 10 per cent fortification level also, sensory attributes of the products begin to become less desirable. Practical implications For the success of nutrition interventions that involve the use of MLP to improve the nutritional quality of complementary foods, there is a need to consider the acceptability of the sensory attributes of the formulated blends in the target group. Safety of MLP as an ingredient in infant foods must also be investigated. Originality/value The authors of this paper make recommendations for the use of MLP to fortify complementary foods to ensure its success as a food fortificant in nutrition interventions. The researchers are not aware of any published study that focuses on this subject.
Cardiovascular diseases (CVDs) are listed as one of the main causes of mortality and morbidity by the World Health Organization. The World Heart Federation lists overweight/obesity, blood lipid profile, and blood pressure as some of the modifiable risk factors to developing CVDs. This study sought to determine the prevalence of some of these modifiable risk factors among University of Ghana students. One hundred and twenty students were sampled for the study. Lipid profile parameters such as high‐density lipoprotein (HDL), total cholesterol (TC), and total triglycerides (TG) were measured using the Vitros 5‐IFS chemistry analyzer (NY, USA). The Friedewald's equation was used to determine low‐density lipoprotein (LDL) levels. Anthropometric indices such as height and weight were measured following standard protocols. Body mass index (BMI) was calculated in kg/m2 using the height and weight measurements. The students were then categorized into underweight, normal, overweight, and obese according to their BMI. Blood pressure measurements were also taken. The mean age of the students was 30.04 ± 7.99 years. A total of 4.2%, 30%, and 67.5% had TG, TC, and LDL, respectively, above normal recommended ranges. Low HDL levels were observed in 32.5% of the students. About 45% had high systolic blood pressure and 32.5% with high diastolic blood pressure. In all, the risk factors studied contributed to about 95% of the variance in explaining the risk of developing CVDs. The study concludes that the cardiovascular risk factors assessed are prevalent among the students and therefore steps must be taken to address the increase in prevalence.
We conclude that complementary foods incorporating Moringa oleifera leaf powder either as part of a cereal-legume complementary food blend (MCL-35 g) or when sprinkled as a food supplement (MS-5 g) on infant's usual foods were well accepted.
Complementary foods that are deficient in both macronutrients and micronutrients coupled with a high burden of infections during the complementary feeding period are major underlying causes of child malnutrition in developing countries. Among the recent efforts to combat malnutrition by improving the quality of complementary foods in the developing world is the use of Moringa oleifera leaf powder (MLP) as a food fortificant. We conducted a randomized controlled trial to test the effect of feeding MLP‐fortified complementary food on hemoglobin concentration and growth of infants and young children after 4 months of feeding. Infants aged 8–12 months were randomly assigned to receive one of three study foods; Weanimix a cereal‐legume blend formulated with Moringa (MCL‐35g), MLP sprinkled on infants’ usual complementary foods (MS‐5g) and the control food Weanimix without Moringa (CF‐35g). Blood samples for hemoglobin determination as well as dietary intake and anthropometric data were collected at baseline and endline for 237 infants who completed the study. Data analysis was performed with SPSS (version 20) and comparisons were done by analysis of covariance (ANCOVA). There were no significant differences in hemoglobin concentration or growth indicators at endline between the three study groups. Findings of this study indicated that feeding infants a 5 g daily dose of MLP, either as part of a cereal‐legume blend or as a supplement which was sprinkled on infants’ usual complementary foods for 4 months, did not significantly improve infants’ hemoglobin concentration or growth indicators.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.